المؤلفون: Mirza, MR, Nyvang, GB, Lund, B, Christensen, RD, Werner, TL, Malander, S, Bjorge, L, Birrer, MJ, Antiila, M, Lindahl, G, Hietanen, S, Dimoula, M, Peen, U, Madsen, K, Knudsen, A, Staff, S, Vinum, NB, Kjelsen, MK, Avall-Lundqvist, E, Maenpaa, JU

المصدر: JOURNAL OF CLINICAL ONCOLOGY. 38(15)

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:144703367

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Bønløkke S; Department of Clinical Medicine, Aarhus University, Denmark.; Department of Pathology, Aarhus University Hospital, Denmark., Steiniche T; Department of Clinical Medicine, Aarhus University, Denmark.; Department of Pathology, Aarhus University Hospital, Denmark., Sorensen BS; Department of Clinical Medicine, Aarhus University, Denmark.; Department of Clinical Biochemistry, Aarhus University Hospital, Denmark., Nyvang GB; Department of Oncology, Odense University Hospital, Denmark., Lindegaard JC; Department of Oncology, Aarhus University Hospital, Denmark., Blaakær J; Department of Obstetrics and Gynecology, Odense University Hospital, Denmark.; Department of Clinical Research, University of Southern Denmark, Odense M, Denmark., Bertelsen J; Department of Pathology, Aarhus University Hospital, Denmark., Fuglsang K; Department of Clinical Medicine, Aarhus University, Denmark.; Department of Obstetrics and Gynecology, Aarhus University Hospital, Denmark., Strube ML; DTU Bioengineering, Technical University of Denmark, Kongens Lyngby, Denmark., Lenz S; Private Gynecological Clinic 'Suzan Lenz Gynækolog', Copenhagen, Denmark., Stougaard M; Department of Clinical Medicine, Aarhus University, Denmark.; Department of Pathology, Aarhus University Hospital, Denmark.

المصدر: Molecular oncology [Mol Oncol] 2024 May; Vol. 18 (5), pp. 1231-1244. Date of Electronic Publication: 2023 Nov 01.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Uterine Cervical Neoplasms*/virology , Uterine Cervical Neoplasms*/blood , Uterine Cervical Neoplasms*/pathology , Uterine Cervical Neoplasms*/diagnosis , DNA, Viral*/blood , DNA, Viral*/genetics, Humans ; Female ; Middle Aged ; Adult ; Cell-Free Nucleic Acids/blood ; Human papillomavirus 16/genetics ; Human papillomavirus 16/isolation & purification ; Biomarkers, Tumor/blood ; Severity of Illness Index ; Aged ; Papillomavirus Infections/virology ; Papillomavirus Infections/diagnosis ; Papillomavirus Infections/complications ; Papillomavirus Infections/blood

المؤلفون: Korsholm LM; Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Kjeldsen M; Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.; Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Perino L; Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Mariani L; Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Nyvang GB; Department of Oncology, Odense University Hospital, Odense, Denmark., Kristensen E; Department of Pathology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Bagger FO; Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Mirza MR; Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Rossing M; Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

المصدر: JCO precision oncology [JCO Precis Oncol] 2024 Feb; Vol. 8, pp. e2300483.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents* , Ovarian Neoplasms*/diagnosis , Ovarian Neoplasms*/drug therapy , Ovarian Neoplasms*/genetics, Humans ; Female ; Poly(ADP-ribose) Polymerase Inhibitors/pharmacology ; Poly(ADP-ribose) Polymerase Inhibitors/therapeutic use ; Homologous Recombination/genetics ; Progression-Free Survival ; Rad51 Recombinase/genetics

المؤلفون: Colombo N; Gynecologic Cancer Program, European Institute of Oncology IRCCS and University of Milan-Bicocca, Milan, Italy., Gadducci A; Clinical and Experimental Medicine, Division of Gynecology and Obstetrics, University of Pisa, Pisa, Italy., Sehouli J; North Eastern German Society of Gynecological Oncology (NOGGO) Study group and Gynecology with Center for Oncological Surgery, European Competence Center for Ovarian Cancer, Charité-Berlin University of Medicine, Berlin, Germany., Rulli E; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy., Mäenpää J; Nordic Society of Gynecologic Oncology Clinical Trial Unit (NSGO-CTU) & Department of Obstetrics and Gynaecology and Tays Cancer Centre Tampere University and University Hospital, Tampere, Finland., Sessa C; Istituto Oncologico della Svizzera Italiana, IOSI and Swiss Group for Clinical Cancer Research (SAKK), Bellinzona, Switzerland., Montes A; Guys and St Thomas' NHS Foundation Trust, London, UK., Ottevanger NB; Medical Oncology, Radboud University Medical Center, Nijmegen, Netherlands., Berger R; Medical University of Innsbruck, Department for Gynecology and Obstetrics, Innsbruck, Austria, and AGO, Innsbruck, Austria., Vergote I; Gynecologic Oncology, University Hospitals Leuven, Leuven Cancer Institute, and Belgian Gynaecological Oncology Group (BGOG), European Union, Leuven, Belgium., D'Incalci M; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy., Churruca Galaz C; Hospital de Donosti San Sebastián and Grupo Español de Cáncer de Ovario (GEICO), de Donosti San, Spain., Chekerov R; North Eastern German Society of Gynecological Oncology (NOGGO) Study group and Gynecology with Center for Oncological Surgery, European Competence Center for Ovarian Cancer, Charité-Berlin University of Medicine, Berlin, Germany., Nyvang GB; Nordic Society of Gynecologic Oncology Clinical Trial Unit (NSGO-CTU) & Department of Oncology, Odense University Hospital, Odense, Denmark., Riniker S; Oncology, Kantonsspital St. Gallen and Swiss Group for Clinical Cancer Research (SAKK), St. Gallen, Switzerland., Herbertson R; Brighton and Sussex University Hospitals NHS Trust, Brighton, UK., Fossati R; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy., Barretina-Ginesta MP; Institut Catalá de Oncología de Girona and Grupo Español de Cáncer de Ovario (GEICO), de Donosti San, Spain., Deryal M; North Eastern German Society of Gynecological Oncology (NOGGO) Study group and CaritasKlinikum St. Theresia-Saarbruecken, Saarbruecken, Germany., Mirza MR; Nordic Society of Gynecologic Oncology Clinical Trial Unit (NSGO-CTU) & Department of Cancer Treatment, Copenhagen University Hospital, Copenhagen, Denmark., Biagioli E; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy. elena.biagioli@marionegri.it., Iglesias M; Hospital Son Llázter and Grupo Español de Cáncer de Ovario (GEICO), Palma, Spain., Funari G; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy., Romeo M; Institut Catalá de Oncología de Badalona and Grupo Español de Cáncer de Ovario (GEICO), de Donosti San, Spain., Tasca G; Oncologia 2, Istituto Oncologico Veneto, Padua, Italy., Pardo B; Institut Catalá de Oncología de Hospitalet and Grupo Español de Cáncer de Ovario (GEICO), Barcelona, Spain., Tognon G; Obstetrics and Gynaecology, ASST Spedali Civili-Università degli Studi di Brescia, Brescia, Italy., Rubio-Pérez MJ; Hospital Reina Sofía Córdoba and Grupo Español de Cáncer de Ovario (GEICO), de Donosti San, Spain., DeCensi A; S.C. Oncologia Medica, E.O. Ospedali Galliera, Genoa, Italy., De Giorgi U; IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Zola P; AOU Città della Salute e della Scienza - OIRM S. Anna, Torino, Italy., Benedetti Panici P; AOU Policlinico Umberto I di Roma, Rome, Italy., Aglietta M; Istituto di Candiolo, FPO-IRCCS and University of Torino, Torino, Italy., Arcangeli V; Ospedale Infermi, Rimini, Italy., Zamagni C; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Bologna A; Azienda Unità Sanitaria Locale di Reggio Emilia IRCCS, Reggio Emilia, Italy., Westermann A; Amsterdam UMC, Amsterdam, Netherlands., Heinzelmann-Schwarz V; Universitätsspital Basel, USB andSwiss Group for Clinical Cancer Research (SAKK), Basel, Switzerland., Tsibulak I; Medical University of Innsbruck, Department for Gynecology and Obstetrics, Innsbruck, Austria, and AGO, Innsbruck, Austria., Wimberger P; North Eastern German Society of Gynecological Oncology (NOGGO) Study group and Department of Gynecology and Obstetrics, Technische Universität Dresden, Fetscherstr, Dresden, Germany.; National Center for Tumor Diseases (NCT/UCC), Dresden, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany., Poveda A; Initia Oncologia and Grupo Español de Cáncer de Ovario (GEICO), Valencia, Spain.

مؤلفون مشاركون: INOVATYON study group

المصدر: British journal of cancer [Br J Cancer] 2023 Apr; Vol. 128 (8), pp. 1503-1513. Date of Electronic Publication: 2023 Feb 09.

نوع المنشور: Randomized Controlled Trial; Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Ovarian Neoplasms*/drug therapy , Ovarian Neoplasms*/etiology, Humans ; Female ; Carboplatin ; Trabectedin ; Platinum/therapeutic use ; Neoplasm Recurrence, Local/drug therapy ; Neoplasm Recurrence, Local/etiology ; Carcinoma, Ovarian Epithelial/drug therapy ; Doxorubicin ; Polyethylene Glycols ; Antineoplastic Combined Chemotherapy Protocols/adverse effects

المؤلفون: Bønløkke S; Department of Clinical Medicine, Aarhus University, 8200 Aarhus, Denmark.; Department of Pathology, Aarhus University Hospital, 8200 Aarhus, Denmark., Stougaard M; Department of Clinical Medicine, Aarhus University, 8200 Aarhus, Denmark.; Department of Pathology, Aarhus University Hospital, 8200 Aarhus, Denmark., Sorensen BS; Department of Clinical Medicine, Aarhus University, 8200 Aarhus, Denmark.; Department of Clinical Biochemistry, Aarhus University Hospital, 8200 Aarhus, Denmark., Booth BB; Department of Obstetrics and Gynecology, Aarhus University Hospital, 8200 Aarhus, Denmark., Høgdall E; Department of Pathology, Herlev Hospital, 2730 Herlev, Denmark., Nyvang GB; Department of Oncology, Odense University Hospital, 5000 Odense, Denmark., Lindegaard JC; Department of Oncology, Aarhus University Hospital, 8200 Aarhus, Denmark., Blaakær J; Department of Obstetrics and Gynecology, Odense University Hospital, 5000 Odense, Denmark.; Department of Clinical Research, University of Southern Denmark, 5230 Odense, Denmark., Bertelsen J; Department of Pathology, Aarhus University Hospital, 8200 Aarhus, Denmark., Fuglsang K; Department of Obstetrics and Gynecology, Aarhus University Hospital, 8200 Aarhus, Denmark., Strube ML; DTU Bioengineering, Technical University of Denmark, 2800 Kongens Lyngby, Denmark., Lenz S; Private Gynecological Clinic 'Suzan Lenz Gynækolog', 2400 Copenhagen, Denmark., Steiniche T; Department of Clinical Medicine, Aarhus University, 8200 Aarhus, Denmark.; Department of Pathology, Aarhus University Hospital, 8200 Aarhus, Denmark.

المصدر: Cells [Cells] 2022 Jul 11; Vol. 11 (14). Date of Electronic Publication: 2022 Jul 11.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101600052 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4409 (Electronic) Linking ISSN: 20734409 NLM ISO Abbreviation: Cells Subsets: MEDLINE

مواضيع طبية MeSH: Cell-Free Nucleic Acids* , Papillomavirus Infections*/complications , Uterine Cervical Neoplasms*/pathology, DNA, Viral/analysis ; DNA, Viral/genetics ; Female ; Human papillomavirus 16/genetics ; Humans ; Papillomaviridae/genetics

المؤلفون: Mirza MR; Nordic Society of Gynaecological Oncology, Copenhagen, Denmark; Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. Electronic address: mansoor.raza.mirza@regionh.dk., Åvall Lundqvist E; Nordic Society of Gynaecological Oncology, Copenhagen, Denmark; Department of Oncology, Linköping University, Linköping, Sweden; Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden., Birrer MJ; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA., dePont Christensen R; Nordic Society of Gynaecological Oncology, Copenhagen, Denmark; Research Unit of General Practice University of Southern Denmark, Odense, Denmark., Nyvang GB; Nordic Society of Gynaecological Oncology, Copenhagen, Denmark; Odense University Hospital, Odense, Denmark., Malander S; Nordic Society of Gynaecological Oncology, Copenhagen, Denmark; Lund University Hospital, Lund, Sweden., Anttila M; Nordic Society of Gynaecological Oncology, Copenhagen, Denmark; Kuopio University Hospital, Kuopio, Finland., Werner TL; University of Utah, Salt Lake City, UT, USA., Lund B; Nordic Society of Gynaecological Oncology, Copenhagen, Denmark; Aalborg University Hospital, Aalborg, Denmark., Lindahl G; Nordic Society of Gynaecological Oncology, Copenhagen, Denmark; Department of Oncology, Linköping University, Linköping, Sweden., Hietanen S; Nordic Society of Gynaecological Oncology, Copenhagen, Denmark; Turku University Hospital, Turku, Finland., Peen U; Nordic Society of Gynaecological Oncology, Copenhagen, Denmark; Herlev University Hospital, Herlev, Denmark., Dimoula M; Nordic Society of Gynaecological Oncology, Copenhagen, Denmark; Sahlgrenska University Hospital, Göteborg, Sweden., Roed H; Nordic Society of Gynaecological Oncology, Copenhagen, Denmark; Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Ør Knudsen A; Nordic Society of Gynaecological Oncology, Copenhagen, Denmark; Odense University Hospital, Odense, Denmark., Staff S; Nordic Society of Gynaecological Oncology, Copenhagen, Denmark; Department of Obstetrics and Gynecology and Tays Cancer Centre, Faculty of Medicine and Health Technology, Tampere University and University Hospital, Tampere, Finland., Krog Vistisen A; Aalborg University Hospital, Aalborg, Denmark., Bjørge L; Nordic Society of Gynaecological Oncology, Copenhagen, Denmark; Department of Obstetrics and Gynecology, Haukeland University Hospital, Bergen, Norway; Center for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Bergen, Norway., Mäenpää JU; Nordic Society of Gynaecological Oncology, Copenhagen, Denmark; Department of Obstetrics and Gynecology and Tays Cancer Centre, Faculty of Medicine and Health Technology, Tampere University and University Hospital, Tampere, Finland.

مؤلفون مشاركون: AVANOVA investigators

المصدر: The Lancet. Oncology [Lancet Oncol] 2019 Oct; Vol. 20 (10), pp. 1409-1419. Date of Electronic Publication: 2019 Aug 29.

نوع المنشور: Clinical Trial, Phase II; Comparative Study; Equivalence Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Carcinoma, Endometrioid/*drug therapy , Indazoles/*therapeutic use , Neoplasm Recurrence, Local/*drug therapy , Ovarian Neoplasms/*drug therapy , Piperidines/*therapeutic use, Aged ; Anemia, Aplastic/chemically induced ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Bevacizumab/administration & dosage ; Carcinoma, Endometrioid/pathology ; Disease Progression ; Female ; Humans ; Hypertension/chemically induced ; Indazoles/administration & dosage ; Indazoles/adverse effects ; Middle Aged ; Neoplasm Grading ; Ovarian Neoplasms/pathology ; Piperidines/administration & dosage ; Piperidines/adverse effects ; Progression-Free Survival ; Proteinuria/chemically induced ; Thrombocytopenia/chemically induced

المؤلفون: Ør Knudsen A; a Department of Oncology , Odense University Hospital ;, Schledermann D; b Department of Pathology , Odense University Hospital ;, Nyvang GB; a Department of Oncology , Odense University Hospital ;, Mogensen O; c Department of Obstetrics and Gynecology , Odense University Hospital ;; d Institute of Clinical Research , University of Southern Denmark , Denmark., Herrstedt J; a Department of Oncology , Odense University Hospital ;; d Institute of Clinical Research , University of Southern Denmark , Denmark.

مؤلفون مشاركون: Academy of Geriatric Cancer Research (AgeCare)

المصدر: Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2016; Vol. 55 Suppl 1, pp. 65-73. Date of Electronic Publication: 2016 Jan 19.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Medical Journals Sweden AB Country of Publication: England NLM ID: 8709065 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1651-226X (Electronic) Linking ISSN: 0284186X NLM ISO Abbreviation: Acta Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Genital Neoplasms, Female/*epidemiology, Age Distribution ; Aged ; Aged, 80 and over ; Combined Modality Therapy ; Denmark/epidemiology ; Early Detection of Cancer ; Female ; Genital Neoplasms, Female/mortality ; Genital Neoplasms, Female/pathology ; Genital Neoplasms, Female/therapy ; Humans ; Incidence ; Mass Screening ; Neoplasm Staging ; Ovarian Neoplasms/epidemiology ; Patient Care Team ; Prevalence ; Prognosis ; Registries ; Risk Factors ; Survival Rate ; Uterine Cervical Neoplasms/epidemiology ; Uterine Neoplasms/epidemiology

المؤلفون: Tanderup K; Department of Oncology, Aarhus University Hospital, Noerrebrogade, Aarhus, Denmark. karitand@rm.dk, Nielsen SK, Nyvang GB, Pedersen EM, Røhl L, Aagaard T, Fokdal L, Lindegaard JC

المصدر: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2010 Feb; Vol. 94 (2), pp. 173-80.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8407192 Publication Model: Print Cited Medium: Internet ISSN: 1879-0887 (Electronic) Linking ISSN: 01678140 NLM ISO Abbreviation: Radiother Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Magnetic Resonance Imaging, Interventional*, Brachytherapy/*methods , Uterine Cervical Neoplasms/*radiotherapy, Dose Fractionation, Radiation ; Female ; Humans ; Imaging, Three-Dimensional ; Lymphatic Metastasis/radiotherapy ; Neoplasm Staging ; Radiotherapy Dosage ; Treatment Outcome ; Uterine Cervical Neoplasms/pathology